TherapeuticsMD (TXMD) Prepaid Assets (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Prepaid Assets came in at $3.5 million in Q2 2026, down 3.04% on a YoY basis from $3.6 million in Q2 2025, and down 2.61% quarter-over-quarter from $3.6 million in Q1 2026.
Analysis
TherapeuticsMD (TXMD) Prepaid Assets (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has reported Prepaid Assets for 17 consecutive years, with $3.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Prepaid Assets fell 3.04% year-over-year to $3.5 million; the trailing twelve-month figure through Jun 2026 stood at $3.5 million (down 3.04% YoY), and the FY2025 full-year result was $3.4 million, down 5.53% from the prior year.
- Prepaid Assets declined to $3.5 million in Q2 2026 per TXMD's latest filing, from $3.6 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $10.3 million in Q3 2022 and bottomed at $3.4 million in Q4 2025.
- Historically, Prepaid Assets has averaged $5.0 million across 5 years, with a median of $3.8 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets advanced 26.72% in 2022, then tumbled 55.59% in 2023.
- Over 5 years, Prepaid Assets stood at $6.0 million in 2022, then tumbled by 33.13% to $4.0 million in 2023, then declined by 9.84% to $3.6 million in 2024, then dropped by 5.53% to $3.4 million in 2025, then gained by 2.94% to $3.5 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $3.5 million, $3.6 million, and $3.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.54 Mn |
| Mar 31, 2026 | 3.63 Mn |
| Dec 31, 2025 | 3.44 Mn |
| Sep 30, 2025 | 3.72 Mn |
| Jun 30, 2025 | 3.65 Mn |
| Mar 31, 2025 | 3.77 Mn |
| Dec 31, 2024 | 3.64 Mn |
| Sep 30, 2024 | 3.78 Mn |
| Jun 30, 2024 | 3.68 Mn |
| Mar 31, 2024 | 3.87 Mn |
| Dec 31, 2023 | 4.04 Mn |
| Sep 30, 2023 | 4.57 Mn |
| Jun 30, 2023 | 5.04 Mn |
| Mar 31, 2023 | 5.45 Mn |
| Dec 31, 2022 | 6.03 Mn |
| Sep 30, 2022 | 10.29 Mn |
| Jun 30, 2022 | 9.10 Mn |
| Mar 31, 2022 | 9.66 Mn |
| Dec 31, 2021 | 5.86 Mn |
| Sep 30, 2021 | 10.37 Mn |